I can't argue with many of the things that have been said except this is a dead carcass. In fact the opportunities are incredible. With the right leadership this company could go a long way. The macro door keeps opening wider and wider.
The regulators are finally getting it:
Here's some additional helpful information on Jayco and pain management.:
Performance Improvement PI.01.01.01: The hospital collects data to monitor its performance. Requirement EP 56: The hospital collects data on pain assessment and pain management including types of interventions and effectiveness. Rationale The collection and analysis of pain assessment and pain management data, including the timing of reassessments, types of interventions and effectiveness, are important in identifying areas that need change to increase safety and quality for patients. For example, data collection on the timing of reassessments may indicate a need for policy or procedure change if patient pain management needs are not being met. Reference* • Frederickson TW, et al. Reducing Adverse Drug Events Related to Opioids
Now let's talk about the Micro: We have a product with 80% efficacy That's non-invasive and has NO side effects. There is no other product on the market that can match that. But Don't take my word for it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.